Trial Profile
Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Beta 2 adrenergic receptor agonists; Budesonide/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 11 Mar 2009 New trial record